MeSH term
Frequency | Condition_Probility | Adult | 4 | 0.0 |
Female | 9 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
HLA-B Antigens/genetics | 6 | 2.0 |
Haplotypes | 7 | 0.0 |
Histocompatibility Antigens Class I/*genetics | 17 | 5.0 |
Histocompatibility Testing | 3 | 0.0 |
Humans | 58 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 5 | 0.0 |
Polymorphism, Genetic | 10 | 0.0 |
Research Support, Non-U.S. Gov't | 36 | 0.0 |
Tumor Necrosis Factor-alpha/genetics | 2 | 0.0 |
Animals | 12 | 0.0 |
Killer Cells, Natural/immunology | 4 | 0.0 |
Ligands | 11 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
Mice | 6 | 0.0 |
Receptors, Immunologic/chemistry/*physiology | 2 | 33.0 |
T-Lymphocytes/immunology | 2 | 0.0 |
Dimerization | 2 | 0.0 |
Killer Cells, Natural/*immunology | 6 | 1.0 |
Models, Molecular | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Evolution, Molecular | 4 | 0.0 |
Base Sequence | 14 | 0.0 |
Gene Frequency | 4 | 0.0 |
HLA-B Antigens/*genetics | 6 | 2.0 |
Introns | 3 | 0.0 |
Microsatellite Repeats | 6 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Alleles | 13 | 0.0 |
Cell Line | 10 | 0.0 |
Genetics, Population | 3 | 0.0 |
HLA Antigens/*genetics | 2 | 0.0 |
Linkage Disequilibrium | 6 | 0.0 |
*Microsatellite Repeats | 2 | 0.0 |
*Alleles | 4 | 0.0 |
Gene Order | 2 | 4.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
DNA | 2 | 0.0 |
Exons | 5 | 0.0 |
*Polymorphism, Genetic | 5 | 0.0 |
Comparative Study | 6 | 0.0 |
English Abstract | 3 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
*Genes, MHC Class I | 7 | 2.0 |
HLA Antigens/genetics | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
*Haplotypes | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Receptors, Immunologic/*metabolism | 6 | 3.0 |
Amino Acid Sequence | 8 | 0.0 |
Histocompatibility Antigens Class I/chemistry/*metabolism | 2 | 50.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Solubility | 2 | 0.0 |
Aged | 2 | 0.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Histocompatibility Antigens Class I/*genetics/immunology | 3 | 11.0 |
Point Mutation | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Cytotoxicity, Immunologic | 4 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Genes, MHC Class I | 2 | 1.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
*Evolution, Molecular | 3 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Histocompatibility Antigens Class I/genetics | 2 | 2.0 |
Major Histocompatibility Complex/*genetics | 2 | 1.0 |
Flow Cytometry | 4 | 0.0 |
Receptors, Antigen, T-Cell, gamma-delta/*immunology | 2 | 4.0 |
Histocompatibility Antigens Class I/chemistry/*genetics | 2 | 33.0 |
Multigene Family | 2 | 0.0 |
Transfection | 5 | 0.0 |
Down-Regulation | 3 | 0.0 |
Histocompatibility Antigens Class I/metabolism | 2 | 3.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
